Patents by Inventor IVONA JASPRICA
IVONA JASPRICA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230158101Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as an N-acetyl amino acid are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl amino acids.Type: ApplicationFiled: January 6, 2023Publication date: May 25, 2023Inventors: Ivona Jasprica, Sabina Keser, Katarina Pindric
-
Patent number: 11628200Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.Type: GrantFiled: March 29, 2021Date of Patent: April 18, 2023Assignee: XELLIA PHARMACEUTICALS APSInventors: Ivona Jasprica, Sabina Keser, Katarina Pindric
-
Patent number: 11517609Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.Type: GrantFiled: July 8, 2022Date of Patent: December 6, 2022Assignee: Xellia Pharmaceuticals ApSInventors: Ivona Jasprica, Sabina Keser, Katarina Pindric
-
Publication number: 20220354927Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.Type: ApplicationFiled: July 8, 2022Publication date: November 10, 2022Applicant: Xellia Pharmaceuticals ApSInventors: Ivona Jasprica, Sabina Keser, Katarina Pindric
-
Publication number: 20220218784Abstract: The present disclosure is related to providing a stable daptomycin aqueous pharmaceutical formulations as a contrast to the inconvenient and potentially problematic methods of lyophilized drug preparation and administration, wherein the aqueous formulations of daptomycin offer the advantage of ease of handling with a high degree of patient acceptability and compliance.Type: ApplicationFiled: May 8, 2020Publication date: July 14, 2022Inventors: Tina Gjoni, Dubravka Strazic-Novakovic, Ivona Jasprica, Stipica Tomic
-
Patent number: 11141417Abstract: Described are voriconazole formulations including 2-hydroxypropyl-?-cyclodextrins and the preparation thereof.Type: GrantFiled: January 24, 2019Date of Patent: October 12, 2021Assignee: XELLIA PHARMACEUTICALS APSInventors: Anita Bevetek Mocnik, Ivona Jasprica, Sasa Grubesic
-
Publication number: 20210220433Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.Type: ApplicationFiled: March 29, 2021Publication date: July 22, 2021Applicant: Xellia Pharmaceuticals APSInventors: Ivona JASPRICA, Sabina Keser, Katarina Pindric
-
Patent number: 11000567Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.Type: GrantFiled: November 7, 2019Date of Patent: May 11, 2021Inventors: Ivona Jasprica, Sabina Keser, Katarina Pindric
-
Patent number: 10849956Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.Type: GrantFiled: December 11, 2018Date of Patent: December 1, 2020Inventors: Ivona Jasprica, Sabina Keser, Katarina Pindric
-
Patent number: 10729708Abstract: Disclosed herein are liquid formulations of glycopeptide antibiotics or pharmaceutically acceptable salts thereof, wherein glycopeptide antibiotic is selected from Vancomycin, Telavancin, Oritavancin, Teicoplanin and Dalbavancin. The formulations are suitable as infusion solutions or as a concentrate for making infusion solutions.Type: GrantFiled: May 4, 2017Date of Patent: August 4, 2020Assignee: Xellia Pharmaceuticals APSInventors: Sabina Keser, Ivona Jasprica, Jerome LeCunff
-
Publication number: 20200069768Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.Type: ApplicationFiled: November 7, 2019Publication date: March 5, 2020Inventors: IVONA JASPRICA, SABINA KESER, KATARINA PINDRIC
-
Publication number: 20190183891Abstract: Described are voriconazole formulations including 2-hydroxypropyl-?-cyclodextrins and the preparation thereof.Type: ApplicationFiled: January 24, 2019Publication date: June 20, 2019Inventors: ANITA BEVETEK MOCNIK, IVONA JASPRICA, SASA GRUBESIC
-
Publication number: 20190175632Abstract: Disclosed herein are liquid formulations of glycopeptide antibiotics or pharmaceutically acceptable salts thereof, wherein glycopeptide antibiotic is selected from Vancomycin, Telavancin, Oritavancin, Teicoplanin and Dalbavancin. Said formulations are suitable as infusion solutions or as a concentrate for making infusion solutions.Type: ApplicationFiled: May 4, 2017Publication date: June 13, 2019Inventors: SABINA KESER, IVONA JASPRICA, JEROME LeCUNFF
-
Publication number: 20190160142Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.Type: ApplicationFiled: December 11, 2018Publication date: May 30, 2019Inventors: IVONA JASPRICA, SABINA KESER, KATARINA PINDRIC
-
Patent number: 10188697Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.Type: GrantFiled: November 6, 2015Date of Patent: January 29, 2019Assignee: XELLIA PHARMACEUTICALS APSInventors: Ivona Jasprica, Sabina Keser, Katarina Pindric
-
Patent number: 10039804Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.Type: GrantFiled: November 30, 2017Date of Patent: August 7, 2018Assignee: XELLIA PHARMACEUTICALS APSInventors: Ivona Jasprica, Sabina Keser, Katarina Pindric
-
Publication number: 20180133286Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.Type: ApplicationFiled: November 30, 2017Publication date: May 17, 2018Inventors: IVONA JASPRICA, SABINA KESER, KATARINA PINDRIC
-
Publication number: 20170348385Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.Type: ApplicationFiled: November 6, 2015Publication date: December 7, 2017Inventors: IVONA JASPRICA, SABINA KESER, KATARINA PINDRIC
-
Publication number: 20150352112Abstract: The present invention relates to new voriconazole formulations comprising 2-hydroxypropyl-?-cyclodextrins and the preparation thereof.Type: ApplicationFiled: January 9, 2014Publication date: December 10, 2015Inventors: ANITA BEVETEK MOCNIK, IVONA JASPRICA, SASA GRUBESIC